Introduction The development of de novo donor-specific antibodies (dnDSA) has been associated with rejection and graft loss in kidney transplantation, and DSA screening is now recommended in all kidney transplant recipients. However, the clinical significance of dnDSA detected by screening patients with a stable creatinine remains unclear. Methods 103 patients
https://ift.tt/2xwPlXI
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου